Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy
Authors:
- Arianna NeriANArianna Neri
- Massimo FabianiMFMassimo Fabiani
- Anna Maria BarbuiABAnna Maria Barbui
- Caterina VocaleCVCaterina Vocale
- Alessandro MigliettaAMAlessandro Miglietta
- Cecilia FazioCFCecilia Fazio
- Anna CarannanteACAnna Carannante
- Annapina PalmieriAPAnnapina Palmieri
- Paola VaccaPVPaola Vacca
- Luigina AmbrosioLALuigina Ambrosio
- Paola StefanelliPaola Stefanelli
Open Access
Abstract
Here, we evaluated over time in different cohorts of children vaccinated against serogroup C Neisseria meningitidis, the presence of antibodies with neutralizing activity. A total of 348 sera samples of enrolled children by year since vaccination (p < 0.001). Children vaccinated with the tetravalent meningococcal serogroup ACWY vaccine resulted in a high proportion of bactericidal rSBA MenC titer ≥ 1:8 (90.6%, 95% CI: 79.3–96.9%) after a mean time of seven months. Overall, the results provide some evidences on the evaluation of meningococcal serogroup C bactericidal antibodies after primary vaccination.Keywords
Funding Information
- Italian Ministry of Health-CCM Project Fasc (1S04)
This publication has 30 references indexed in Scilit:
- Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2–10-year-old children: results of an open, randomised, controlled studyEuropean Journal of Pediatrics, 2013
- Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C VaccineClinical and Vaccine Immunology, 2010
- Serogroup C meningococci in Italy in the era of conjugate menC vaccinationBMC Infectious Diseases, 2009
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- TheNeisseria meningitidisCapsule Is Important for Intracellular Survival in Human CellsInfection and Immunity, 2007
- A surveillance network for meningococcal disease in EuropeFEMS Microbiology Reviews, 2007
- Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccineVaccine, 2006
- Meningococcal surrogates of protection?serum bactericidal antibody activityVaccine, 2005
- Antibody Persistence and Immunological Memory at Age 4 Years after Meningococcal Group C Conjugate Vaccination in Children in the United KingdomThe Journal of Infectious Diseases, 2002
- Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK ToddlersThe Journal of Infectious Diseases, 2001